Fifth Third Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Sell
5,360
-334
-6% -$22.3K 0.01% 613
2026
Q1
$358K Buy
5,694
+394
+7% +$27.4K 0.01% 536
2025
Q4
$352K Sell
5,300
-466
-8% -$30.1K 0.01% 513
2025
Q3
$388K Sell
5,766
-212
-4% -$16.8K 0.01% 464
2025
Q2
$522K Sell
5,978
-1,065
-15% -$83.5K 0.02% 353
2025
Q1
$481K Buy
7,043
+908
+15% +$74.1K 0.02% 338
2024
Q4
$477K Sell
6,135
-23,511
-79% -$1.74M 0.03% 343
2024
Q3
$1.99M Buy
29,646
+22,334
+305% +$1.83M 0.12% 124
2024
Q2
$829K Buy
+7,312
New +$924K 0.06% 185

Other funds holding DXCM

Fifth Third Wealth Advisors's DXCM Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its DexCom (DXCM) stake by 5.9% in Q2 2026, selling an estimated $22.3K and leaving 5,360 shares worth $361K. The position accounts for 0.01% of the portfolio, ranked #613.

Fifth Third Wealth Advisors first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.99M in Q3 2024. 115 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Fifth Third Wealth Advisors held 5,360 shares of DexCom worth $361K as of Q2 2026.
  • Fifth Third Wealth Advisors sold 334 DexCom shares in Q2 2026, an estimated $22.3K.
  • DexCom made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #613 holding.
  • Fifth Third Wealth Advisors first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • Fifth Third Wealth Advisors's DexCom position peaked at $1.99M in Q3 2024.
  • 115 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.